Patients screened had type 2 diabetes were treated with basal insulin for at least 6 months, receiving a stable daily dose of between 15 and 40 units alone or combined with 1 or 2 OADs (metformin, sulfonylurea, glinide, SGLT-2 inhibitor or a DPP-4 inhibitor), had an HbA1c between 7.5% and 10% and a FPG less than or equal to 180 mg/dL or 200 mg/dL depending on their previous antidiabetic treatment
The findings indicate that a single dosage of BNT162b2 generates a robust humoral and cellular immune response in most of CML patients, and nilotinib may correlate with improved T-cell functioning [321]
Wang JX, You DY, Wang HP, et al
Semaglutide is a GLP-1 receptor agonist that mimics naturally occurring hormones to regulate appetite and improve satiety
B12 Intramuscular Injection The B12 injection delivers Methylcobalamin directly into the tissues, ensuring fast and efficient absorption